First mRNA Flu Vaccine Shows Stronger, Longer-Lasting Immunity Than Standard Shots
A New Approach to Flu Protection
Moderna's mRNA-based flu vaccine, mFlusiva, represents a significant advancement in influenza immunization. Clinical data indicates that this first-generation mRNA flu vaccine generates stronger and longer-lasting immunity compared to conventional flu shots.
Why mRNA Technology Matters
mRNA vaccines work by instructing cells to